Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David F. Hale
AddedMar 31, 2024
UpdatedJun 28, 2026
David F. Hale

David F. Hale

Board Member, Biocept

Crunchbase

David F. Hale's Career

Biocept
Biocept

San Diego, CA, US

Board Member· Board
Oncternal Therapeutics
Oncternal Therapeutics

San Diego, CA, US

Board Member· Board
Mdrejuvena
Mdrejuvena

San Diego, CA, US

Founder & CEO· C-Suite · Management
Viagene
Viagene

Lutz, FL, US

Founder
BioClarity
BioClarity

San Diego, CA, US

Founder
Recros Medica
Recros Medica

San Diego, CA, US

Board Member· Board
Neurana Pharmaceuticals
Neurana Pharmaceuticals

San Diego, CA, US

Board Member· Board
Neurelis
Neurelis

San Diego, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David F. Hale's Career

Biocept
Biocept

San Diego, CA, US

Board Member· Board
Oncternal Therapeutics
Oncternal Therapeutics
Public$132M302013San Diego, CA, US
Board Member· Board

Leadership at Oncternal Therapeutics

Lauren OtsukiLauren OtsukiFounder
Michael G. CarterMichael G. CarterBoard Member
William R. LaRueWilliam R. LaRueBoard Member
Daniel KisnerDaniel KisnerBoard Member
Cam GallagherCam GallagherBoard Member
Charles TheuerCharles TheuerBoard Member
Mdrejuvena
Mdrejuvena
Seed$3M302015San Diego, CA, US
Founder & CEO· C-Suite · Management

Similar to Mdrejuvena

Renew You MedspaRenew You MedspaHudson, MA, USMedical Aestheticsest. 2021Renew You MedspaHudson, MA, US · est. 2021

Massachusetts-based manufacturing firm and women-owned Renew You Med Spa, specializing in aesthetic medicine.

Angel · $75k5
OluraOluraFranklin, TN, USBeauty Devicesest. 2016OluraFranklin, TN, US · est. 2016

OLURA: Providing clinical-grade beauty devices for astonishing at-home results.

Angel · $200k30
MD CompleteMD CompleteTerrace Park, OH, USCosmetics, Skincareest. 2012MD CompleteTerrace Park, OH, US · est. 2012

MD Complete Skincare: Premium, cruelty-free skincare solutions including acne and anti-aging treatments.

Private Equity · $7.4M30
CellCeuticals Skin CareCellCeuticals Skin CareBeverly Hills, CA, USCosmetics, Skincareest. 2007CellCeuticals Skin CareBeverly Hills, CA, US · est. 2007

CellCeuticals Skin Care, Inc.: A US-based consumer goods company specializing in skincare.

Pre-Seed · $7.6M30
Viagene
Viagene
Seed$1M6Lutz, FL, US
Founder

Similar to Viagene

VirogenomicsVirogenomicsPortland, OR, USBiotech Consultingest. 2001VirogenomicsPortland, OR, US · est. 2001

Virogenomics BioDevelopment, based in Portland, aids in transitioning early-stage biotech innovations from labs to market, ensuring maximum impact.

Pre-Seed · $587.4k30
BioClarity
BioClarity

San Diego, CA, US

Founder
Recros Medica
Recros Medica
Series A$14.7M192014San Diego, CA, US
Board Member· Board

Leadership at Recros Medica

Edward KnowltonEdward KnowltonCo-Founder
Tom AlbrightTom AlbrightBoard Member
Cathy McCarthyCathy McCarthyCo-Founder
Neurana Pharmaceuticals
Neurana Pharmaceuticals
Series A$60M52013San Diego, CA, US
Board Member· Board

Leadership at Neurana Pharmaceuticals

Alex ZissonAlex ZissonBoard Member
David S. KabakoffDavid S. KabakoffBoard Member
Judy CaronJudy CaronFounder
J Craig ThompsonJ Craig ThompsonCEO
Neurelis
Neurelis
Public$206.1M1382007San Diego, CA, US
Board Member· Board

Leadership at Neurelis

Craig ChamblissCraig ChamblissCo-Founder
Cam GarnerCam GarnerBoard Member
David SmithDavid SmithBoard Member
Steve CarttSteve CarttBoard Member

Similar to Neurelis

NeurolixisNeurolixisSan Diego, CA, USPharmaceuticalsest. 2011NeurolixisSan Diego, CA, US · est. 2011

San Diego-based Neurolixis, a biopharmaceutical firm innovating treatments for central nervous system diseases.

Seed · $15k6
NeuroPro TherapeuticsNeuroPro TherapeuticsYachats, OR, USPharmaceuticalsest. 2014NeuroPro TherapeuticsYachats, OR, US · est. 2014

NeuroPro Therapeutics: Developing pharmaceutical solutions for epilepsy and neurological disorders.

Series A · $5.1M5
NeuroTherapeutics PharmaNeuroTherapeutics PharmaChicago, IL, USPharmaceuticals, Therapeuticsest. 2006NeuroTherapeutics PharmaChicago, IL, US · est. 2006

NeuroTherapeutics Pharma: A US-based biopharmaceutical firm specializing in neuropathic and acute pain treatments.

Public · $60.7M30
Neurana PharmaceuticalsNeurana PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2013Neurana PharmaceuticalsSan Diego, CA, US · est. 2013

Neurana Pharmaceuticals: A US-based specialty pharma company innovating treatments for CNS diseases.

Series A · $60M5

David F. Hale's Co-Investors

David PyottDavid PyottCo-invested · SeedGerry ProehlGerry ProehlCo-invested · SeedYann PhungYann PhungCo-invested · Seed

David F. Hale's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to David F. Hale

Antonino MoralesAntonino MoralesCEO · BioceptBruce E. GerhardtBruce E. GerhardtBoard Member · BioceptM. Faye WilsonM. Faye WilsonBoard Member · BioceptMarsha A. ChandlerMarsha A. ChandlerBoard Member · BioceptAnita DavidsonAnita DavidsonCo-Founder · Creative BioTherapeuticsBenjamin CappielloBenjamin CappielloCo-Founder · Bioceptive